PCN Insights, News, Videos, and More
Videos
12/04/2023
With Vladimir Maletic, MD
With Vladimir Maletic, MD
Dr Maletic discusses how new research shows promise for advancing our comprehension of brain networks, circuits, and neurotransmitters to benefit those with neurological and psychiatric disorders
Dr Maletic discusses how new research shows promise for advancing our comprehension of brain networks, circuits, and neurotransmitters to benefit those with neurological and psychiatric disorders
Dr Maletic discusses how new...
12/04/2023
Psychiatry & Behavioral Health
News
12/04/2023
Incorporating drug-drug interactions and lifestyle factors into pharmacogenomics-guided medication management contributed to improved remission rates in patients with major depressive disorder, according to a poster presentation at Psych...
Incorporating drug-drug interactions and lifestyle factors into pharmacogenomics-guided medication management contributed to improved remission rates in patients with major depressive disorder, according to a poster presentation at Psych...
Incorporating drug-drug...
12/04/2023
Psych Congress Network
News
12/01/2023
A poster recently presented at NEI Congress 2023 suggests the use of aripiprazole lauroxil (AL), an LAI atypical antipsychotic for schizophrenia, as a versatile option supported by its pharmacokinetic, efficacy, and safety characteristics.
A poster recently presented at NEI Congress 2023 suggests the use of aripiprazole lauroxil (AL), an LAI atypical antipsychotic for schizophrenia, as a versatile option supported by its pharmacokinetic, efficacy, and safety characteristics.
A poster recently presented at...
12/01/2023
Psych Congress Network
News
12/01/2023
Adult attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of dementia, according to cohort study results published in JAMA Network Open.
Adult attention-deficit/hyperactivity disorder (ADHD) was associated with an increased risk of dementia, according to cohort study results published in JAMA Network Open.
Adult...
12/01/2023
Psych Congress Network
News
11/30/2023
Researchers have identified a potential link between decreased slow-wave sleep (SWS)—a crucial sleep cycle phase—and Alzheimer risk.
Researchers have identified a potential link between decreased slow-wave sleep (SWS)—a crucial sleep cycle phase—and Alzheimer risk.
Researchers have identified a...
11/30/2023
Psych Congress Network
News
11/28/2023
Solriamfetol improved objective and subjective measures of cognitive function in patients with cognitive impairment associated with obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS), according to a poster presentation at...
Solriamfetol improved objective and subjective measures of cognitive function in patients with cognitive impairment associated with obstructive sleep apnea (OSA) and excessive daytime sleepiness (EDS), according to a poster presentation at...
Solriamfetol improved objective...
11/28/2023
Psych Congress Network
News
11/28/2023
BIIB080 reduced biomarkers associated with tau pathophysiology in patients with mild Alzheimer disease, according to results from a phase 1b trial published in JAMA Neurology.
BIIB080 reduced biomarkers associated with tau pathophysiology in patients with mild Alzheimer disease, according to results from a phase 1b trial published in JAMA Neurology.
BIIB080 reduced biomarkers...
11/28/2023
Psych Congress Network
News
11/28/2023
Tom Valentino, Digital Managing Editor
A study conducted by researchers in the Netherlands has found that microdosing psychedelics for 4 weeks induced an increase in mindfulness and a decrease in neuroticism among adults diagnosed with attention-deficit/hyperactivity disorder...
A study conducted by researchers in the Netherlands has found that microdosing psychedelics for 4 weeks induced an increase in mindfulness and a decrease in neuroticism among adults diagnosed with attention-deficit/hyperactivity disorder...
A study conducted by researchers...
11/28/2023
Psych Congress Network
News
11/27/2023
Tom Valentino, Digital Managing Editor
Compass Pathways, which recently opened a new research center in London, has begun a multi-site study of investigational psilocybin treatment of treatment-resistant depression.
Compass Pathways, which recently opened a new research center in London, has begun a multi-site study of investigational psilocybin treatment of treatment-resistant depression.
Compass Pathways, which recently...
11/27/2023
Psych Congress Network
Videos
11/27/2023
Featuring Vladimir Maletic, MD.
Featuring Vladimir Maletic, MD.
...
Vladimir Maletic, MD, explores the complexities of brain circuitry and the neurobiological basis of major psychiatric conditions.
Vladimir Maletic, MD, explores the complexities of brain circuitry and the neurobiological basis of major psychiatric conditions.
Vladimir Maletic, MD, explores...
11/27/2023
Psychiatry & Behavioral Health
